# A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers

> **NCT00698022** · PHASE1 · COMPLETED · sponsor: **Corcept Therapeutics** · enrollment: 76 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Risperidone
- **DRUG:** Mifepristone
- **DRUG:** Risperidone-matched placebo
- **DRUG:** Mifepristone-matched placebo

## Key facts

- **NCT ID:** NCT00698022
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2022-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00698022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00698022, "A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00698022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*